ImportRefusal LogoImportRefusal

Novartis International Ag

⚠️ Moderate Risk

FEI: 3001059001 • Basel, Basel Stadt • SWITZERLAND

FEI

FEI Number

3001059001

📍

Location

Basel, Basel Stadt

🇨🇭
🏢

Address

Mattenstrasse 22, , Basel, Basel Stadt, Switzerland

Moderate Risk

FDA Import Risk Assessment

46.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
5
Unique Violations
3/5/2010
Latest Refusal
7/25/2003
Earliest Refusal

Score Breakdown

Violation Severity
78.1×40%
Refusal Volume
42.5×30%
Recency
0.0×20%
Frequency
19.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7510×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4721×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
3/5/2010
62GCY90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
11/22/2006
60LCE99ANALGESIC, N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/1/2006
61NCY99ANTI-DEPRESSANT N.E.C.
472NO ENGLISH
75UNAPPROVED
Florida District Office (FLA-DO)
2/16/2006
68YIS20ANIMAL DRUGS N.E.C. USED MORE THAN 1 SPECIES
72NEW VET DR
New Orleans District Office (NOL-DO)
10/21/2005
61JCA10FLUVASTATIN SODIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/23/2005
62LCA99ANTI-PROTOZOAL, ANTI-LEISHMANIAL, ANTI-MALARIAL, N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
4/6/2005
62CDA99ANTI-HYPERTENSIVE N.E.C.
75UNAPPROVED
Florida District Office (FLA-DO)
3/7/2005
62CDB99ANTI-HYPERTENSIVE N.E.C.
75UNAPPROVED
Florida District Office (FLA-DO)
3/7/2005
62IIS99ANTI-NEOPLASTIC N.E.C.
16DIRECTIONS
New York District Office (NYK-DO)
3/3/2005
62IIS99ANTI-NEOPLASTIC N.E.C.
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
4/12/2004
65ADB03TACRINE HYDROCHLORIDE (MEMORY ADJUVANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/3/2004
60ECA02AMINOGLUTETHIMIDE (ADRENOCORTICAL SUPPRESSANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
7/25/2003
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Novartis International Ag's FDA import refusal history?

Novartis International Ag (FEI: 3001059001) has 13 FDA import refusal record(s) in our database, spanning from 7/25/2003 to 3/5/2010.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novartis International Ag's FEI number is 3001059001.

What types of violations has Novartis International Ag received?

Novartis International Ag has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novartis International Ag come from?

All FDA import refusal data for Novartis International Ag is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.